TSSI:NASDAQTSS, Inc. Analysis
Data as of 2026-05-06 - not real-time
$17.09
Latest Price
8/10Risk
Risk Level: High
Executive Summary
TSS, Inc. (TSSI) is trading at $17.09, well below its DCF‑derived fair value of roughly $28.70, implying a material upside despite the model’s modest 5.3% estimate. The stock sits comfortably above its 20‑day (≈14.93) and 50‑day (≈12.87) simple moving averages, and the MACD line has just edged past its signal line, generating a bullish histogram, while the RSI of 64 indicates strength without being overbought. Volatility is extreme, with a 30‑day price swing near 100% and a computed beta of 3.65, underscoring high market sensitivity. Recent headlines highlight a 19.5% price surge on strong AI‑driven data‑center demand and the addition of seasoned technology veterans to the executive team, reinforcing growth expectations. Fundamentals show 21.8% revenue growth, a solid ROE of 36%, but a negative free cash flow and a debt‑to‑equity ratio of 54%, suggesting capital constraints. Compared with an industry PE average of 37.2, TSSI’s PE of 30.5 appears relatively cheap, though its price‑to‑book of 6.15 is elevated against a book value of $2.78 per share. The combination of strong top‑line momentum, undervaluation relative to peers, and heightened risk from volatility and leverage frames a nuanced picture.
Given the bullish technical setup, AI‑centric growth narrative, and valuation upside, a short‑to‑medium‑term buying stance is warranted, while long‑term exposure should be moderated by the company’s cash‑flow challenges and beta‑driven price swings.
Given the bullish technical setup, AI‑centric growth narrative, and valuation upside, a short‑to‑medium‑term buying stance is warranted, while long‑term exposure should be moderated by the company’s cash‑flow challenges and beta‑driven price swings.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price above 20‑day and 50‑day SMAs with bullish MACD crossover
- Strong AI/data‑center demand driving recent price rally
- Undervalued relative to DCF fair value and industry PE
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust 21.8% revenue growth and high ROE
- Projected upside from DCF valuation and analyst expectations
- Executive hires adding credibility to AI‑focused strategy
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Negative free cash flow and elevated debt‑to‑equity ratio
- High beta and near‑100% 30‑day volatility increasing price risk
- Sustained growth potential in AI infrastructure but execution risk
Key Metrics & Analysis
Financial Health
Revenue Growth21.80%
Profit Margin6.16%
P/E Ratio30.5
ROE36.11%
ROA4.72%
Debt/Equity54.33
P/B Ratio6.2
Op. Cash Flow$34.9M
Free Cash Flow$-6252500
Industry P/E37.2
Technical Analysis
TrendNeutral
RSI64.4
Support$12.01
Resistance$17.38
MA 20$14.93
MA 50$12.87
MA 200$13.72
MACDBullish
VolumeDecreasing
Fear & Greed Index90.54
Valuation
Fair Value$28.70
Target Price$18.00
Upside/Downside5.32%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta3.65
Volatility99.72%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.